NewAge, Inc. announced the discovery of a new method to support cardiovascular health and anti-aging, and has filed for a patent to protect its multiple unique claims regarding a recent publication in the Journal of Biosciences and Medicine.
Included in this patent is a new way to unblock the secretion signal from the hypothalmus, stimulating the anterior pituitary gland to naturally secrete human growth hormone (HGH).
“The filing of this patent and unveiling of this unique discovery is an incredible achievement in both science and technology to help people take control of the aging process and age healthy,” said Brett West, NewAge’s Senior Director of Research. “This is the first product to simultaneously address specific multiple pathways by which Human Growth Hormone declines in the body. The results from our laboratory studies and trials represent real scientific breakthrough with globally relevant applications, and we are incredibly proud of the team that contributed to the discovery.”
Cardiovascular health decline can be attributed in part to the increase of dipeptidyl-peptidase 4 (DPP4), which sends signals to the anterior pituitary. Combining Tahitian NONI fruit and pterostilbene, NewAge scientists found a way to unblock the DPP4 signal by 99.1%, triggering the body to naturally regulate itself.
“This is the first time that scientists have ascertained how to simultaneously address these specific pathways by which HGH declines in the body,” said Deanna Latson, NewAge’s Chief Product Officer. “As a result, we can now trigger the body’s natural regeneration process and support cellular health. No other product to our knowledge can improve cell regeneration, inhibit cellular apoptosis, support physical resilience, boost energy and stamina, and combat other adverse effects of aging.”
